MedPath

Stress-MRI Assessment After Right Coronary Artery CTO Recanalization

Not Applicable
Completed
Conditions
Ischemic Heart Disease
Coronary Artery Disease
Coronary Atherosclerosis
Coronary Artery Stenosis
Interventions
Procedure: CTO coronary angioplasty
Drug: Optimal medicamentous treatment
Procedure: Stress-MRI
Registration Number
NCT02769650
Lead Sponsor
Meshalkin Research Institute of Pathology of Circulation
Brief Summary

The hypothesis of this study is that Stress-MRI is a clinically significant method of myocardial perfusion assessment after coronary angioplasty with stenting of right coronary artery (RCA) chronic total occlusion (CTO) is performed.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
72
Inclusion Criteria
  • Stable angina, CCS FC II-IV
  • "Right-dominance" coronary circulation according to coronary angiography
  • Absence of other significant atherosclerotic coronary lesions (more than 65%)
  • High risk of myocardium ischemia according to stress-MRI data (perfusion defect in 2 or more segments in the area of interest)
  • Signed, documented informed consent prior to admission to the study
Exclusion Criteria
  • Acute coronary syndrome
  • Contraindications for adenosine stress test
  • Low and moderate risk of myocardium ischemia according to stress-MRI data (perfusion defect in less than 2 segments in the area of interest)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Stress-MRI + Chronic total occlusion PCICTO coronary angioplastyPre- and postoperative stress-MRI with evaluation of myocardium perfusion defects + Coronary angioplasty with stenting of RCA CTO
Stress-MRI + Chronic total occlusion PCIStress-MRIPre- and postoperative stress-MRI with evaluation of myocardium perfusion defects + Coronary angioplasty with stenting of RCA CTO
Stress-MRI + Optimal medicamentous treatmentOptimal medicamentous treatmentPre- and postoperative stress-MRI with evaluation of myocardium perfusion defects + Optimal medicamentous treatment
Stress-MRI + Optimal medicamentous treatmentStress-MRIPre- and postoperative stress-MRI with evaluation of myocardium perfusion defects + Optimal medicamentous treatment
Primary Outcome Measures
NameTimeMethod
Stress-MRI evaluationWithin 2 and 12 month after hospitalization

High risk of myocardium ischemia according to stress-MRI data (perfusion defect in 2 or more segments in the area of interest)

Secondary Outcome Measures
NameTimeMethod
Major adverse cardiac and cerebrovascular events (MACCE)During 1 year after first stress-MRI assessment

Major adverse cardiac and cerebrovascular events (MACCE) including: All-cause mortality, Myocardial infarction, Stroke, Stent thrombosis, Clinically indicated Target lesion revascularization, Any target lesion revascularization, Any target vessel revascularization.

Stress-MRI evaluation (2)Within 2 and 12 month after hospitalization

Dynamics of perfusion in myocardium scar tissue according to stress-MRI data

Clinical assessmentWithin 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12 moths after hospitalization

Dynamical assessment of stable angina FC (CCS) and dyspnea FC (NYHA)

Trial Locations

Locations (1)

State Research Institute of CIrculation Pathology

🇷🇺

Novosibirsk, Russian Federation

© Copyright 2025. All Rights Reserved by MedPath